Notification, 15 June 1988.
The effect of this Notification is to prohibit the manufacture and sale of the following in India: fixed-dose combinations of estrogen and progestin (other than oral contraceptives) having, per tablet, an estrogen content of more than 50 mcg (equivalent to ethinyl estradiol) and a progestin content of more than 3 mg (equivalent to norethisterone acetate).
D001208:Asia; D003257:Consumer Product Safety; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D003906:Developing Countries; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D007194:India; D019359:Knowledge; D007878:Legislation as Topic; D009640:Norethindrone
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol; D009640:Norethindrone
Asia; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Developing Countries; Ethinyl Estradiol; Family Planning; India; Knowledge; Legislation; Norethindrone; Norethindrone Acetate; Product Approval; Southern Asia